Induction of Immune Rejection of Tumors by Protein A in Mice Bearing Transplantable Solid Tissue Dalton's Lymphoma Tumors

References

• Adams D. O., Choen M. S., Koren H. S. Macrophage Mediated Antibody Dependent Cellular Cytoxocity, H. S. Koren. Marcel Dekker, New York 1983; 43
   Google Scholar
• Adams D. O., Johnson W. J., Marino P. A. Mechanism of target recognition and destruction in macropnage mediated tumor cytotoxicity. Fed. Proc. 1982; 41: 2212
   PubMedGoogle Scholar
• Adams D. O., Marino P. Contemporary Hematology-Oncology, A. S. Gordon, R. Silber, J. LoBue. Plenum Press, New York 1984; Vol. 3: 69
   Google Scholar
• Asherson G. I., Zembala M. Suppressor T cell in cell mediated immunity. Br. Med. Bull. 1976; 32: 158
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Ray P. K. Introduction of bacterial component in post adsorbed plasma during adsorption of Staphylococcus aureus. Cancer 1985; 56: 266
   PubMed Web of Science ®Google Scholar
• Catalona W. J., Ratliff T. L., McCool R. E. Interferon induced by. S. aureus Protein A augments natural killer and ADCC. Nature 1981; 291: 77
   PubMed Web of Science ®Google Scholar
• Das C., Langone J. J. Correlation between antitumor activity of Protein A and in vivo formation of defined high molecular weight complexes with immunoglobulin G in BALB/c mice. Cancer Res. 1987; 47: 2002
   PubMed Web of Science ®Google Scholar
• Dwivedi P. D., Misra A., Gupta G. S. D., Dutta K. K., Das S. M., Ray P. K. Inhalation toxicity studies on methyl isocyanate (MIC) in rats: Part IV-Immunologic response in rats one week after exposure: Effect on body and organ weight, phagocytic and DTH response. Ind. J. Exp. Biol 1988; 26: 191
   PubMed Web of Science ®Google Scholar
• Forsgren A., Ghetie V., Landmark R., Sjoquist J. Staphylococci and Staphylococcal Infection, C. Adamson. Academic Press, New York 1983; Vol. 2: 429
   Google Scholar
• Forsgren A., Sjoquist J. Protein A from Staphylococcus aureus III. Reaction with rabbit ĝ- globulin. J. Immunol. 1967; 99: 19
   PubMed Web of Science ®Google Scholar
• Goto Mitsuoka M. A., Sugiyama M., Kitano M. Ehancement of delayed hyper sensitivity reaction with varieties of anti cancer drugs. A common biological phenomenon. J. Exp. Med. 1981; 154: 204
   PubMed Web of Science ®Google Scholar
• Greene M. I. The genetic and cellular basis of regulation of the immune response to tumor antigens. Comtep. Topics Immunobiol. 1980; 11: 81
   PubMedGoogle Scholar
• Greene M. I., Nelles M. J., Sy M. S., Nisonoff A. Regulation of immunity to the azo-benzene arsonate heptene. Adv. Immunol. 1982; 32: 254
   Web of Science ®Google Scholar
• Gresser I., Maury C, Brouty-Boye D. On the mechanism of the antitumor effect of interferon. Nature (Lon.) 1972; 239: 167
   PubMed Web of Science ®Google Scholar
• Hamilton T. A., Fishman M., Crawford G., Look A. T. Sensitivity to macrophage mediated cytostasis is cell cycle dependent. Cell. Immunol. 1982; 69: 363
   PubMed Web of Science ®Google Scholar
• Hellstrom I, Hellstrom K. E. Cell medicated suppression of tumor immunity as non specific component 2. Evidence from cell culture experiments. Int. J. Cancer 1981; 27: 487
   PubMed Web of Science ®Google Scholar
• Herberman R. B., Aoki T., Nunn M. E., Lavrin Saares D. H., Gadzar N., Holden A. T., Chang K. S.S. Specificity of Cr51 release cytotoxicity of lymphocyte immune to murine sarcoma virus. J. Natl. Cancer. Inst. 1984; 52: 1103
   Google Scholar
• Johnson W. J., Bolognesi D., Adams D. O. Antibody dependent cytolysis (ADCC) of tumor cell by activated murine macrophages is a two step process quantification of target binding and subsequent target lysis. Cell Immunol. 1983; 83: 170
   Web of Science ®Google Scholar
• Koller L. D., Roan J. G., Brouner J. A. Methylmercury: Effect of B lymphocyte receptor and phagocytosis of macrophages. J. Environ. Pathol. Toxicol. 1980; 3: 407
   PubMedGoogle Scholar
• Kwalezyk D., Fourmier M., Potwsoriwski EF. Age dependent accumulation of thymic hormones sensitive cells. Thymes. 1981; 3: 335
   PubMedGoogle Scholar
• Prasad A. K., Singh K. P., Saxena A. K., Mathur N., Ray P. K. Increased macrophage activity in Protein A treated tumor regressed animals. Immunopharmacol. Immunotoxicol. 1987; 9: 541
   PubMed Web of Science ®Google Scholar
• Ray P. K. Immunobiology of transplantation cancer and pregnancy, P. K. Ray. Pergman Press, New York 1983a; 210
   Google Scholar
• Ray P. K., Bandyopadhyay S. Plasma elution of biomolecules from non viable Staphylococcus aureus Cowan I. Fed. Am. See. Exp. Biol. 1982a; 41: 1556
   Google Scholar
• Ray P. K., Bandyopadhyay S. Inhibition of rat mammary tumor growth by purified protein A - a potential anti-tumor agent. Immunol. Commun. 1983b; 12: 1
   PubMedGoogle Scholar
• Dohadwala M., Canchanapan P., Mobini J. Antitumor activity of non toxic doses of Protein A. Cancer Immunol. Immunother. 1984a; 18: 29
   PubMed Web of Science ®Google Scholar
• Ray P. K., McLaughlin D., Mohammed J., Idiculla A., Rhoads J. E., Jr, Mark R., Bassett J. G., Cooper D. R. Immune complexes and plasma exchanges in cancer patients, B. Serrou, C. Rosenfeld. Elsevier/North Holland, Amsterdam 1981a; 97
   Google Scholar
• Ray P. K., Mohammad J., Allen P., Raychaudhuri S., Dohadwala M., Bandyopadhyay S. K., Mark R. Effect of frequency of plasma adsorption over Protein A containing Staphylococcus aureus on regression rat mammary adenocarcinoma: Modification of antitumor immune response and tumor histopathology. J. Biol. Resp. Modif. 1984b; 3: 39
   PubMedGoogle Scholar
• Ray P. K., Raychaudhari S., Allen P. Mechanism of regression of mammary adenocarcinoma in rats following plasma adsorption over Protein A containing Staphylococcus aureus. Cancer Res. 1982b; 42: 4970
   PubMed Web of Science ®Google Scholar
• Ray P. K., Raychaudhari S. Low doses cyclophosphamide inhibition of transplantable firbosarcoma growth by augmentation of host immune response. J. Natl. Cancer Inst. 1981b; 67: 1341
   PubMedGoogle Scholar
• Romagnani S., Amadori A., Gudizi M. G., Biagiotti R., Maggi E., Ricci M. Different mitogenic activity of soluble and insoluble staphylococcal Protein A (SPA). Immunology 1978; 35: 471
   PubMed Web of Science ®Google Scholar
• Sakane T., Green I. Protein A from Staphylococcus aureus a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes. J. Immunol. 1978; 120: 302
   PubMed Web of Science ®Google Scholar
• Sukumar S., Zbar B., Teraz N., Langone J. J. Plasma therapy of primary rat mammary carcinoma: Antitumor activity of tumor bearer plasma adsorbed against inactivated CNBr sepharose or protein A - sepharose. J. Biol. Resp. Modif. 1984; 3: 305
   Google Scholar
• Schuurman R. K., Gelfand E. W., Dosch H. M. Polyclonal activation of human lymphocytes in vivo I. Characterisation of the lynphocyte response to a T cell dependent B cell mitogen. J. Immunol. 1980; 125: 820
   PubMed Web of Science ®Google Scholar
• Terman D. S., Yamamoto J., Mattioli M. Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowan I. Description of acute tumoricidal response: morphologic, histologic, immunohistochemical, immunologic and serologic finding. J. Immunol. 1980; 24: 795
   Google Scholar
• Terman D. S., Young J. B., Sheerer W. J. Preliminary observation of the effects on breast adenocarcinoma of plasma perfused over immobilized proteinA. N. Engal. J. Med. 1981; 305: 1195
   PubMed Web of Science ®Google Scholar